Equities researchers at StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS - Get Free Report) in a research report issued on Wednesday. The firm set a "hold" rating on the stock.
Separately, Benchmark reaffirmed a "speculative buy" rating and issued a $1.25 price objective on shares of Milestone Scientific in a research note on Wednesday, November 20th.
Check Out Our Latest Research Report on Milestone Scientific
Milestone Scientific Stock Down 8.7 %
MLSS stock traded down $0.08 during mid-day trading on Wednesday, reaching $0.81. 208,261 shares of the stock traded hands, compared to its average volume of 115,554. The business has a 50-day moving average of $0.82 and a two-hundred day moving average of $0.85. Milestone Scientific has a 52 week low of $0.52 and a 52 week high of $1.10. The firm has a market capitalization of $62.79 million, a PE ratio of -11.52 and a beta of 1.10.
Insider Buying and Selling at Milestone Scientific
In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total transaction of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares of the company's stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Over the last ninety days, insiders have sold 109,193 shares of company stock valued at $101,634. 24.75% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Milestone Scientific
Several institutional investors have recently added to or reduced their stakes in MLSS. World Investment Advisors LLC acquired a new stake in Milestone Scientific in the 3rd quarter valued at $91,000. Y Intercept Hong Kong Ltd acquired a new stake in Milestone Scientific in the 3rd quarter valued at $48,000. Finally, Geode Capital Management LLC increased its stake in Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company's stock valued at $480,000 after buying an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by institutional investors.
Milestone Scientific Company Profile
(
Get Free Report)
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
Before you consider Milestone Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.
While Milestone Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
